| Exosome as a novel shuttle for delivery of therapeutics across biological barriers CK Das, BC Jena, I Banerjee, S Das, A Parekh, SK Bhutia, M Mandal Molecular pharmaceutics 16 (1), 24-40, 2018 | 224 | 2018 |
| Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo A Parekh, S Das, S Parida, CK Das, D Dutta, SK Mallick, PH Wu, ... Oncogene 37 (33), 4546-4561, 2018 | 84 | 2018 |
| The transformation of cancer-associated fibroblasts: Current perspectives on the role of TGF-β in CAF mediated tumor progression and therapeutic resistance BC Jena, S Sarkar, L Rout, M Mandal Cancer Letters 520, 222-232, 2021 | 69 | 2021 |
| The emerging roles of exosomes in anti-cancer drug resistance and tumor progression: An insight towards tumor-microenvironment interaction BC Jena, M Mandal Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1875 (1), 188488, 2021 | 68 | 2021 |
| Cancer associated fibroblast mediated chemoresistance: A paradigm shift in understanding the mechanism of tumor progression BC Jena, CK Das, D Bharadwaj, M Mandal BBA-Reviews on Cancer, 2020 | 66 | 2020 |
| S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway KK Dey, R Bharti, G Dey, I Pal, Y Rajesh, S Chavan, S Das, CK Das, ... Cancer gene therapy 23 (11), 382-391, 2016 | 43 | 2016 |
| Paracrine TGF-β1 from breast cancer contributes to chemoresistance in cancer associated fibroblasts via upregulation of the p44/42 MAPK signaling pathway BC Jena, CK Das, I Banerjee, S Das, D Bharadwaj, R Majumder, ... Biochemical Pharmacology 186, 114474, 2021 | 42 | 2021 |
| TGF-β1 induced autophagy in cancer associated fibroblasts during hypoxia contributes EMT and glycolysis via MCT4 upregulation BC Jena, CK Das, I Banerjee, D Bharadwaj, R Majumder, S Das, ... Experimental Cell Research 417 (1), 113195, 2022 | 32 | 2022 |
| Pre-clinical risk assessment and therapeutic potential of antitumor lipopeptide ‘Iturin A’in an in vivo and in vitro model G Dey, R Bharti, I Banerjee, AK Das, CK Das, S Das, BC Jena, M Misra, ... RSC advances 6 (75), 71612-71623, 2016 | 25 | 2016 |
| Causes of cancer: physical, chemical, biological carcinogens, and viruses S Das, M Kundu, BC Jena, M Mandal Biomaterials for 3D Tumor Modeling, 607-641, 2020 | 24 | 2020 |
| Screening of the Prime bioactive compounds from Aloe vera as potential anti-proliferative agents targeting DNA R Majumder, CK Das, I Banerjee, BC Jena, A Mandal, P Das, AK Pradhan, ... Computers in Biology and Medicine 141, 105052, 2022 | 21 | 2022 |
| Understanding the function and regulation of Sox2 for its therapeutic potential in breast cancer A Dey, M Kundu, S Das, BC Jena, M Mandal Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1877 (2), 188692, 2022 | 19 | 2022 |
| Active autophagy in cancer‐associated fibroblasts: Recent advances in understanding the novel mechanism of tumor progression and therapeutic response BC Jena, L Rout, A Dey, M Mandal Journal of cellular physiology 236 (11), 7887-7902, 2021 | 15 | 2021 |
| Real-time monitoring of a photoactivated hydrogen persulfide donor for biological entities A Chaudhuri, Y Venkatesh, BC Jena, KK Behara, M Mandal, NDP Singh Organic & Biomolecular Chemistry 17 (39), 8800-8805, 2019 | 13 | 2019 |
| Photoresponsive block copolymer prodrug nanoparticles as delivery vehicle for single and dual anticancer drugs G Biswas, BC Jena, S Maiti, P Samanta, M Mandal, D Dhara Acs Omega 2 (10), 6677-6690, 2017 | 13 | 2017 |
| Synthesis, self-assembly and drug release study of a new dual-responsive biocompatible block copolymer containing phenylalanine derivative G Biswas, BC Jena, P Samanta, M Mandal, D Dhara Journal of Macromolecular Science, Part A 58 (11), 792-803, 2021 | 12 | 2021 |
| A copper-free click reaction for the synthesis of redox-responsive water-soluble core cross-linked nanoparticles for drug delivery in cancer therapy G Biswas, BC Jena, S Sahoo, P Samanta, M Mandal, D Dhara Green Chemistry 21 (20), 5624-5638, 2019 | 10 | 2019 |
| A novel computational predictive biological approach distinguishes Integrin β1 as a salient biomarker for breast cancer chemoresistance S Das, M Kundu, A Hassan, A Parekh, BC Jena, S Mundre, I Banerjee, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1869 (6), 166702, 2023 | 8 | 2023 |
| A two-photon responsive hydroxyphenylquinazolinone (HPQ)-based fluorescent organic nanoprodrug for H 2 S release against oxidative stress A Chaudhuri, T Singha, BC Jena, M Shee, PK Datta, M Mandal, ... Chemical Communications 59 (9), 1177-1180, 2023 | 2 | 2023 |
| Biochemical pharmacology of adenylyl cyclases in cancer BC Jena, DP Flaherty, VP O'Brien, VJ Watts Biochemical Pharmacology, 116160, 2024 | 1 | 2024 |
Mahitosh MandalProfessor, School of Medical Science and Technology,Indian Institute of Technology, Kharagpur, IndiaVerified email at smst.iitkgp.ac.in